메뉴 건너뛰기




Volumn 32, Issue 1, 2009, Pages 135-137

Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; N(G) METHYLARGININE; NITRIC OXIDE; PLACEBO; XANTHINE OXIDASE;

EID: 64549134738     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1179     Document Type: Article
Times cited : (29)

References (11)
  • 1
    • 0018764335 scopus 로고
    • Diabetes and Cardiovascular-Disease: The Framingham study
    • Kannel WB, Mcgee DL: Diabetes and Cardiovascular-Disease: the Framingham study. JAMA 241:2035-2038, 1979
    • (1979) JAMA , vol.241 , pp. 2035-2038
    • Kannel, W.B.1    Mcgee, D.L.2
  • 2
    • 0037337344 scopus 로고    scopus 로고
    • Megherbi SE, Milan C, Minier D, Cou-vreurG,Osseby GV, Tilling K, Di Carlo A, Inzitari D, Wolfe CDA, Moreau T, Giroud M: Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 34:688-694, 2003
    • Megherbi SE, Milan C, Minier D, Cou-vreurG,Osseby GV, Tilling K, Di Carlo A, Inzitari D, Wolfe CDA, Moreau T, Giroud M: Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke 34:688-694, 2003
  • 3
    • 33645337656 scopus 로고    scopus 로고
    • Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes
    • Nazir FS, Alem M, Small M, Connell JM, Lees KR, Walters MR, Cleland SJ: Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes. Diabet Med 23:398-402, 2006
    • (2006) Diabet Med , vol.23 , pp. 398-402
    • Nazir, F.S.1    Alem, M.2    Small, M.3    Connell, J.M.4    Lees, K.R.5    Walters, M.R.6    Cleland, S.J.7
  • 4
    • 0031908926 scopus 로고    scopus 로고
    • Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercap-nia
    • White RP, Deane C, Vallance P, Markus HS: Nitric oxide synthase inhibition in humans reduces cerebral blood flow but not the hyperemic response to hypercap-nia. Stroke 29:467-472, 1998
    • (1998) Stroke , vol.29 , pp. 467-472
    • White, R.P.1    Deane, C.2    Vallance, P.3    Markus, H.S.4
  • 5
    • 0034065857 scopus 로고    scopus 로고
    • Allopurinol normalizes en-dothelial dysfunction in type 2 diabetics with mild hypertension
    • Butler R, Morris AD, Belch JJ, Hill A, Struthers AD: Allopurinol normalizes en-dothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 35: 746-751, 2000
    • (2000) Hypertension , vol.35 , pp. 746-751
    • Butler, R.1    Morris, A.D.2    Belch, J.J.3    Hill, A.4    Struthers, A.D.5
  • 6
    • 0036210192 scopus 로고    scopus 로고
    • Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo
    • Wilkinson IB, MacCallum H, Cockcroft JR, Webb DJ: Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 53:189-192, 2002
    • (2002) Br J Clin Pharmacol , vol.53 , pp. 189-192
    • Wilkinson, I.B.1    MacCallum, H.2    Cockcroft, J.R.3    Webb, D.J.4
  • 7
    • 0034625073 scopus 로고    scopus 로고
    • Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superox-ide production in human internal mammary arteries
    • Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Do-miniczak AF: Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superox-ide production in human internal mammary arteries. Circulation 101:2206 -2212, 2000
    • (2000) Circulation , vol.101 , pp. 2206-2212
    • Berry, C.1    Hamilton, C.A.2    Brosnan, M.J.3    Magill, F.G.4    Berg, G.A.5    McMurray, J.J.6    Do-miniczak, A.F.7
  • 8
    • 33751023105 scopus 로고    scopus 로고
    • Uric acid and xan-thine oxidase: Future therapeutic targets in the prevention of cardiovascular disease?
    • Dawson J, Walters M: Uric acid and xan-thine oxidase: future therapeutic targets in the prevention of cardiovascular disease? Br J Clin Pharmacol 62:633- 644, 2006
    • (2006) Br J Clin Pharmacol , vol.62 , pp. 633-644
    • Dawson, J.1    Walters, M.2
  • 9
    • 34547489857 scopus 로고    scopus 로고
    • Uric acid reduction: A new paradigm in the management of cardiovascular risk?
    • Dawson J, Quinn T, Walters M: Uric acid reduction: a new paradigm in the management of cardiovascular risk? Curr Med Chem 14:1879-1886, 2007
    • (2007) Curr Med Chem , vol.14 , pp. 1879-1886
    • Dawson, J.1    Quinn, T.2    Walters, M.3
  • 10
    • 0033133528 scopus 로고    scopus 로고
    • Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus
    • O'Driscoll G, Green D, Maiorana A, Stanton K,Colreavy F, Taylor R:Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 33:1506-1511, 1999
    • (1999) J Am Coll Cardiol , vol.33 , pp. 1506-1511
    • O'Driscoll, G.1    Green, D.2    Maiorana, A.3    Stanton, K.4    Colreavy, F.5    Taylor, R.6
  • 11
    • 17844408136 scopus 로고    scopus 로고
    • Lipid-independent effects of statins on endothelial function and bio-availability of nitric oxide in hypercholes-terolemic patients
    • John S, Schneider MP, Delles C, Jacobi J, Schmieder RE: Lipid-independent effects of statins on endothelial function and bio-availability of nitric oxide in hypercholes-terolemic patients. Am Heart J 149:473, 2005
    • (2005) Am Heart J , vol.149 , pp. 473
    • John, S.1    Schneider, M.P.2    Delles, C.3    Jacobi, J.4    Schmieder, R.E.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.